🕵️ Avalyn Pharma Inc. ($AVLN)
SEC insider & ownership activity, last 12 months · CIK 1540171 · every row links its SEC filing
Over the last 12 months insiders bought $25.0M with no open-market selling against it. SR One Capital Management, LLC bought $10.0M in discretionary trades (May). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
3 buyers, $25.0M (4 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| SR One Capital Management, LLC | 2 | $10.0M | 0 | – | May 1, 2026 |
| NOVO Holdings A/S | 1 | $10.0M | 0 | – | May 1, 2026 |
| Carroll Jill | 1 | $5.0M | 0 | – | May 1, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FMR LLC | 11.5% | 13G | May 5, 2026 | filing ↗ | |
| Abigail P. Johnson | 11.5% | 13G | May 5, 2026 | filing ↗ | |
| Simeon George | 7.5% | 13D | May 1, 2026 | filing ↗ | |
| SR One Capital Management, LLC | 7.5% | 13D | May 1, 2026 | filing ↗ | |
| Perceptive Advisors LLC | 6.0% | 13G | May 7, 2026 | filing ↗ | |
| Joseph Edelman | 6.0% | 13G | May 7, 2026 | filing ↗ | |
| Suvretta Capital Management, LLC | 5.6% | 13D | May 1, 2026 | filing ↗ | |
| Aaron Cowen | 5.6% | 13D | May 1, 2026 | filing ↗ | |
| Perceptive Xontogeny Venture Fund II, L.P | 5.1% | 13G | May 7, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 17, 2026 | filing ↗ |
| Earnings (2.02) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |